A Phase III, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients View this Trial
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM View this Trial
Effect of Dapagiflozin on hepatic glucose metabolism: role of autonomic nervous system View this Trial
Bariatric Surgeries and Glucose Metabolism View this Trial
A study attempting to improve the comfort during screening mammography (CTMS# 16-0045) View this Trial
Molecular Analysis for Therapy Choice (MATCH) MATCH Treatment Subprotocol H: EAY131-H: Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations (Excluding Melanoma, Thyroid Cancer, and Colorectal Adenocarcinoma) (CTMS# 15-2083)
View this Trial
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119) View this Trial
AGCT1532: A randomized phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumors) View this Trial
NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) Screening Protocol View this Trial
A multi-center, double-blind, placebo-controlled, Phase 4 study in patients with pulmonary arterial hypertension to assess the effect of selexipag on daily life physical activity and patient’s self-reported symptoms and their impacts View this Trial
ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections) View this Trial
